Skip to main content
SpringerLink
Log in

Adalimumab

Latent tuberculosis and presumed septic shock: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Al-Sohaim A, et al. The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy. Annals of Saudi Medicine 41: 285-292, No. 5, Sep 2021. Available from: URL: http://doi.org/10.5144/0256-4947.2021.285

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1907, 25 (2022). https://doi.org/10.1007/s40278-022-15284-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-15284-z

Search

Navigation